ARTELO BIOSCIENCES, INC. (ARTL) earnings per share
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-12-31 | -$37.56 | 2026-02-24 |
| FY 2024 | 2024-12-31 | -$54.90 | 2025-03-03 |
| FY 2023 | 2023-12-31 | -$56.52 | 2024-03-25 |
| FY 2019 | 2019-08-31 | -$394.20 | 2019-11-25 |
| FY 2018 | 2018-08-31 | -$496.80 | 2018-11-29 |
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | -$4.00 | 2026-05-14 |
| Q4 2025 | 2025-12-31 | -$0.12 | 2026-02-24 |
| Q3 2025 | 2025-09-30 | -$11.91 | 2025-11-12 |
| Q2 2025 | 2025-06-30 | -$16.83 | 2025-08-13 |
| Q1 2025 | 2025-03-31 | -$12.55 | 2025-05-13 |
| Q4 2024 | 2024-12-31 | -$21.06 | 2025-03-03 |
| Q3 2024 | 2024-09-30 | -$6.30 | 2024-11-12 |
| Q2 2024 | 2024-06-30 | -$13.56 | 2024-08-13 |
| Q1 2024 | 2024-03-31 | -$14.04 | 2024-05-13 |
| Q4 2023 | 2023-12-31 | -$17.82 | 2024-03-25 |
| Q3 2023 | 2023-09-30 | -$14.94 | 2023-11-13 |
| Q2 2021 | 2021-02-28 | — | 2021-04-13 |
| Q3 2020 | 2020-05-31 | — | 2020-07-13 |
| Q2 2020 | 2020-02-29 | -$108.00 | 2020-04-13 |
| Q1 2020 | 2019-11-30 | -$108.00 | 2020-01-14 |
| Q4 2019 | 2019-08-31 | -$113.40 | 2019-11-25 |
| Q3 2019 | 2019-05-31 | -$108.00 | 2019-07-15 |
| Q2 2019 | 2019-02-28 | -$108.00 | 2019-04-15 |
| Q1 2019 | 2018-11-30 | -$86.40 | 2019-01-14 |
| Q4 2018 | 2018-08-31 | -$197.10 | 2018-11-29 |
| Q3 2018 | 2018-05-31 | -$97.20 | 2018-07-13 |
| Q2 2018 | 2018-02-28 | -$18.90 | 2018-04-16 |
| Q1 2018 | 2017-11-30 | — | 2018-01-16 |
| Period | End | FCF / Share | Filed |
|---|---|---|---|
| Q2 2021 | 2021-02-28 | -$0.05 | 2021-04-13 |
| Q3 2020 | 2020-05-31 | -$0.27 | 2020-07-13 |
| Q2 2020 | 2020-02-29 | -$193.51 | 2020-04-13 |
| Q3 2018 | 2018-05-31 | -$185.98 | 2018-07-13 |
| Q2 2018 | 2018-02-28 | -$0.03 | 2018-04-16 |
| Q1 2018 | 2017-11-30 | $0.00 | 2018-01-16 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from
the matching 10-Q; Q4 is derived as full-year minus nine-month
YTD because XBRL doesn't tag Q4 as its own period.
EPS Basic and EPS Diluted
are reported directly by the filer.
FCF / Share is computed as
(Operating Cash Flow − Capital Expenditures) ÷ Diluted
Shares Outstanding. When SEC companyfacts omits the
direct diluted-share concept for an older period, we
imply it from NetIncomeLoss ÷ EarningsPerShareDiluted.
For financial filers whose operating cash flow includes
customer-fund activity (e.g. Mercado Pago deposits),
FCF may materially exceed net income because the fintech
float is recorded inside OCF under US GAAP.
Per-share values are split-adjusted
to the current share count (3 split
s since
2022).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
ARTL CIK 0001621221 Source: EDGAR filings · all facts